Moleculin Biotech, Inc. 8-K

What Happened Moleculin Biotech, Inc. filed a Form 8-K on March 19, 2026 reporting a Regulation FD disclosure: the company is using and has posted a corporate investor presentation on its website. The presentation is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: March 19, 2026 (Form 8-K). Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• Exhibit included: 99.1 — Investor Presentation dated March 19, 2026.
• Interactive data: cover page Inline XBRL file submitted as Exhibit 104.

Why It Matters This 8-K notifies investors that Moleculin has made an official corporate presentation publicly available under Regulation FD, ensuring material information is shared broadly and simultaneously. Investors should review the Exhibit 99.1 presentation (or the company website) for the latest corporate updates and any data that could inform investment decisions.